The electrophysiology component of this Core will screen conotoxins for their functional activities against known ion channel targets as well as identify possible new targets for novel conotoxins. This will be pursued at three levels, with each succesive level having decreased scope but increased specificity. A) Extracellular recording from skeletal muscle and motor, sensory, and sympathetic nerves in isolated tissue preparations will be used to obtain a global assessment of a toxin's activity. B) Whole-cell voltage clamping of dissociated neurons will be used to focus in on the general nature of the channel affected by the toxin (e.g., Navs K; fast- vs slow-inactivating, etc.). C) The specific channel isotype targeted by the toxin will be pinpointed by examining the toxin's effect on cloned channels expressed in Xenopus oocytes. Levels B and C will also address the mechanism of toxin-action. The histology component of the Core will identify the sites of conotoxin binding in excitable tissues by light microscopy. Toward this end, conopeptides will be labeled with the following reporter groups: (a) fluorophores, for direct viewing by fluorescence microscopy; (b) 125I, for use with autoradiography and viewing by dark field microscopy; and (c) biotin, for use with avidin conjugated to HRP for histochemical staining and avidin conjugated with fluorophores for fluorescence microsocopy. These experiments assessing the locations of the cellular and subcelluar binding sites of toxins will complement the physiological experiments assessing the toxins' effects on target function.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM048677-12
Application #
7551074
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
Budget Start
2004-02-01
Budget End
2005-01-31
Support Year
12
Fiscal Year
2004
Total Cost
$92,240
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Yan, Yijin; Peng, Can; Arvin, Matthew C et al. (2018) Nicotinic Cholinergic Receptors in VTA Glutamate Neurons Modulate Excitatory Transmission. Cell Rep 23:2236-2244
Hone, Arik J; McIntosh, J Michael (2018) Nicotinic acetylcholine receptors in neuropathic and inflammatory pain. FEBS Lett 592:1045-1062
Hone, Arik J; Talley, Todd T; Bobango, Janet et al. (2018) Molecular determinants of ?-conotoxin potency for inhibition of human and rat ?6?4 nicotinic acetylcholine receptors. J Biol Chem 293:17838-17852
Banala, Sambashiva; Arvin, Matthew C; Bannon, Nicholas M et al. (2018) Photoactivatable drugs for nicotinic optopharmacology. Nat Methods 15:347-350
Hone, Arik J; Servent, Denis; McIntosh, J Michael (2018) ?9-containing nicotinic acetylcholine receptors and the modulation of pain. Br J Pharmacol 175:1915-1927
Espino, Samuel S; Robinson, Samuel D; Safavi-Hemami, Helena et al. (2018) Conopeptides promote itch through human itch receptor hMgprX1. Toxicon 154:28-34
Richter, Katrin; Sagawe, Sabrina; Hecker, Andreas et al. (2018) C-Reactive Protein Stimulates Nicotinic Acetylcholine Receptors to Control ATP-Mediated Monocytic Inflammasome Activation. Front Immunol 9:1604
Hiller, Sebastian Daniel; Heldmann, Sarah; Richter, Katrin et al. (2018) ?-Nicotinamide Adenine Dinucleotide (?-NAD) Inhibits ATP-Dependent IL-1? Release from Human Monocytic Cells. Int J Mol Sci 19:
Peng, Can; Yan, Yijin; Kim, Veronica J et al. (2018) Gene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission. Eur J Neurosci :
Chen, De-Jie; Gao, Fen-Fei; Ma, Xiao-Kuang et al. (2018) Pharmacological and functional comparisons of ?6/?3?2?3-nAChRs and ?4?2-nAChRs heterologously expressed in the human epithelial SH-EP1 cell line. Acta Pharmacol Sin 39:1571-1581

Showing the most recent 10 out of 277 publications